Gossamer Bio, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Gossamer Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
  • Gossamer Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $5M, a 39% decline year-over-year.
  • Gossamer Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $29.1M, a 8.3% decline year-over-year.
  • Gossamer Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $28.5M, a 33% decline from 2022.
  • Gossamer Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $42.6M, a 32.9% increase from 2021.
  • Gossamer Bio, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $32M, a 17.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $28.5M -$14M -33% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $42.6M +$10.5M +32.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $32M -$6.74M -17.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 $38.7M +$17.9M +86.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-17
2019 $20.8M -$10.1M -32.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-03
2018 $30.9M +$30.9M +96609% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $32K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.